PVE/PVL Combined With DEB-TACE in the Treatment of Patients With Large and Unresectable Liver Cancer
Condition(s):Hepatocellular CarcinomaLast Updated:December 19, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Hepatocellular CarcinomaLast Updated:December 19, 2023Recruiting
Condition(s):Hepatocellular CarcinomaLast Updated:September 13, 2023Recruiting
Condition(s):Hepatocellular Carcinoma; Chemoembolization, Therapeutic; Ablation Techniques, RFALast Updated:October 13, 2016Unknown status
Condition(s):Primary Hepatocellular CarcinomaLast Updated:February 23, 2017Unknown status
Condition(s):Antineoplastic Combined Chemotherapy ProtocolsLast Updated:December 29, 2017Unknown status
Condition(s):Unresectable Hepatocellular CarcinomaLast Updated:June 22, 2023Recruiting
Condition(s):Unresectable Hepatocellular CarcinomaLast Updated:October 17, 2022Recruiting
Condition(s):Hepatocellular Carcinoma Non-resectable; Transarterial Chemoembolization; Microwave AblationLast Updated:May 7, 2019Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.